"Treatment Outcome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
| Descriptor ID |
D016896
|
| MeSH Number(s) |
E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
|
| Concept/Terms |
Clinical Effectiveness- Clinical Effectiveness
- Clinical Effectivenesses
- Effectiveness, Clinical
- Effectivenesses, Clinical
- Patient-Relevant Outcome
- Outcome, Patient-Relevant
- Outcomes, Patient-Relevant
- Patient Relevant Outcome
- Patient-Relevant Outcomes
- Clinical Efficacy
- Efficacy, Clinical
|
Below are MeSH descriptors whose meaning is more general than "Treatment Outcome".
Below are MeSH descriptors whose meaning is more specific than "Treatment Outcome".
This graph shows the total number of publications written about "Treatment Outcome" by people in this website by year, and whether "Treatment Outcome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 40 | 41 |
| 1996 | 0 | 38 | 38 |
| 1997 | 2 | 55 | 57 |
| 1998 | 0 | 73 | 73 |
| 1999 | 1 | 80 | 81 |
| 2000 | 1 | 67 | 68 |
| 2001 | 3 | 98 | 101 |
| 2002 | 1 | 103 | 104 |
| 2003 | 1 | 148 | 149 |
| 2004 | 1 | 179 | 180 |
| 2005 | 2 | 191 | 193 |
| 2006 | 4 | 215 | 219 |
| 2007 | 2 | 263 | 265 |
| 2008 | 1 | 273 | 274 |
| 2009 | 1 | 287 | 288 |
| 2010 | 3 | 363 | 366 |
| 2011 | 2 | 424 | 426 |
| 2012 | 1 | 368 | 369 |
| 2013 | 2 | 471 | 473 |
| 2014 | 2 | 440 | 442 |
| 2015 | 1 | 421 | 422 |
| 2016 | 7 | 462 | 469 |
| 2017 | 5 | 522 | 527 |
| 2018 | 3 | 498 | 501 |
| 2019 | 1 | 455 | 456 |
| 2020 | 2 | 483 | 485 |
| 2021 | 5 | 425 | 430 |
| 2022 | 0 | 367 | 367 |
| 2023 | 0 | 332 | 332 |
| 2024 | 0 | 417 | 417 |
| 2025 | 0 | 95 | 95 |
To return to the timeline,
click here.
Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France. Blood Adv. 2025 May 27; 9(10):2530-2541.
-
Risk of Coronary Obstruction in Redo-Transcatheter Aortic Valve Replacement Between Bicuspid and Tricuspid Aortic Valves. JACC Cardiovasc Interv. 2025 May 12; 18(9):1174-1185.
-
Management and Outcomes of Clostridioides difficile Infection in Patients on Immune Checkpoint Inhibitors. J Natl Compr Canc Netw. 2025 05; 23(5):147-155.
-
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial. J Natl Cancer Inst. 2025 May 01; 117(5):889-897.
-
Frailty in Pediatric Liver Disease May Be Associated With an Increased Incidence of Readmissions After Pediatric Liver Transplantation. Pediatr Transplant. 2025 May; 29(3):e70077.
-
Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial. Clin Cancer Res. 2025 May 01; 31(9):1587-1595.
-
Procedure Costs Associated With Management of Biliary Strictures in Pediatric Liver Transplant Recipients in the Society of Pediatric Liver Transplantation (SPLIT) Registry. Pediatr Transplant. 2025 May; 29(3):e70009.
-
Central Nervous System Histoplasmosis: A Retrospective Review of Clinical Characteristics, Treatments and Outcomes With Comparison to Disseminated Histoplasmosis Without Central Nervous System Involvement. Mycoses. 2025 May; 68(5):e70068.
-
Impact of High-Titer Convalescent Plasma on Clinical and Virologic Outcomes Among Veterans Hospitalized With SARS-CoV-2 Infection: VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1). J Med Virol. 2025 May; 97(5):e70349.
-
Percutaneous transluminal angioplasty and stenting (PTAS) in patients with symptomatic intracranial vertebrobasilar artery stenosis (IVBS). Stroke Vasc Neurol. 2025 Apr 29; 10(2).